These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

270 related items for PubMed ID: 12890207

  • 1. An evaluation of the usefulness of mycophenolate mofetil in pemphigus.
    Powell AM, Albert S, Al Fares S, Harman KE, Setterfield J, Bhogal B, Black MM.
    Br J Dermatol; 2003 Jul; 149(1):138-45. PubMed ID: 12890207
    [Abstract] [Full Text] [Related]

  • 2. Mycophenolate mofetil and enteric-coated mycophenolate sodium in the treatment of pemphigus vulgaris and pemphigus foliaceus.
    Doukaki S, Platamone A, Alaimo R, Bongiorno MR.
    J Dermatolog Treat; 2015 Feb; 26(1):67-72. PubMed ID: 24521072
    [Abstract] [Full Text] [Related]

  • 3. Mycophenolate mofetil: a new therapeutic option in the treatment of blistering autoimmune diseases.
    Grundmann-Kollmann M, Korting HC, Behrens S, Kaskel P, Leiter U, Krähn G, Kerscher M, Peter RU.
    J Am Acad Dermatol; 1999 Jun; 40(6 Pt 1):957-60. PubMed ID: 10365927
    [Abstract] [Full Text] [Related]

  • 4. Treatment of pemphigus vulgaris with mycophenolate mofetil as a steroid-sparing agent.
    Esmaili N, Chams-Davatchi C, Valikhani M, Farshidfar F, Parvaneh N, Tamizifar B.
    Eur J Dermatol; 2008 Jun; 18(2):159-64. PubMed ID: 18424375
    [Abstract] [Full Text] [Related]

  • 5. Mycophenolate mofetil as adjuvant in pemphigus vulgaris.
    Sarma N, Ghosh S.
    Indian J Dermatol Venereol Leprol; 2007 Jun; 73(5):348-50. PubMed ID: 17921620
    [Abstract] [Full Text] [Related]

  • 6. Mycophenolate mofetil for the management of autoimmune bullous diseases.
    Eskin-Schwartz M, David M, Mimouni D.
    Dermatol Clin; 2011 Oct; 29(4):555-9. PubMed ID: 21924997
    [Abstract] [Full Text] [Related]

  • 7. [Open trial of mycophenolate mofetil in the treatment of resistant pemphigus vulgaris].
    Chams-Davatchi C, Nonahal Azar R, Daneshpazooh M, Valikhani M, Hallaji Z, Barzegari M, Firouz AR, Zakeri M.
    Ann Dermatol Venereol; 2002 Jan; 129(1 Pt 1):23-5. PubMed ID: 11937925
    [Abstract] [Full Text] [Related]

  • 8. Treatment of refractory blistering autoimmune diseases with mycophenolic acid.
    Marzano AV, Dassoni F, Caputo R.
    J Dermatolog Treat; 2006 Jan; 17(6):370-6. PubMed ID: 17853312
    [Abstract] [Full Text] [Related]

  • 9. Efficacy and safety of long-term mycophenolate sodium therapy in pemphigus vulgaris.
    Baskan EB, Yilmaz M, Tunali S, Saricaoglu H.
    J Eur Acad Dermatol Venereol; 2009 Dec; 23(12):1432-4. PubMed ID: 19470052
    [Abstract] [Full Text] [Related]

  • 10. Mycophenolate mofetil as an adjuvant therapy for classic and endemic pemphigus foliaceus.
    Kawashita MY, Tsai K, Aoki V, Santi CG, Maruta CW, Rivitti E.
    J Dermatol; 2005 Jul; 32(7):574-80. PubMed ID: 16335874
    [Abstract] [Full Text] [Related]

  • 11. Mycophenolate mofetil in autoimmune and inflammatory skin disorders.
    Nousari HC, Sragovich A, Kimyai-Asadi A, Orlinsky D, Anhalt GJ.
    J Am Acad Dermatol; 1999 Feb; 40(2 Pt 1):265-8. PubMed ID: 10025760
    [Abstract] [Full Text] [Related]

  • 12. Use of mycophenolate mofetil in the treatment of paraneoplastic pemphigus.
    Williams JV, Marks JG, Billingsley EM.
    Br J Dermatol; 2000 Mar; 142(3):506-8. PubMed ID: 10735959
    [Abstract] [Full Text] [Related]

  • 13. Mycophenolate mofetil as a first-line steroid-sparing agent in the treatment of pemphigus vulgaris.
    Vyas N, Patel NS, Cohen GF.
    J Drugs Dermatol; 2013 Feb; 12(2):210-6. PubMed ID: 23377396
    [Abstract] [Full Text] [Related]

  • 14. [IgA pemphigus. Successful treatment with mycophenolate mofetil].
    Burchardt T, Büchau A, Ruzicka T, Megahed M.
    Hautarzt; 2004 Apr; 55(4):387-9. PubMed ID: 15021936
    [Abstract] [Full Text] [Related]

  • 15. Successful treatment with mycophenolate mofetil of four Japanese patients with pemphigus vulgaris.
    Koga H, Ishii N, Hamada T, Karashima T, Nakama T, Yasumoto S, Hashimoto T.
    Eur J Dermatol; 2010 Apr; 20(4):472-5. PubMed ID: 20406724
    [Abstract] [Full Text] [Related]

  • 16. Mycophenolate is effective in the treatment of pemphigus vulgaris.
    Enk AH, Knop J.
    Arch Dermatol; 1999 Jan; 135(1):54-6. PubMed ID: 9923781
    [Abstract] [Full Text] [Related]

  • 17. Mycophenolate mofetil versus azathioprine in patients with chronic active ulcerative colitis: a 12-month pilot study.
    Orth T, Peters M, Schlaak JF, Krummenauer F, Wanitschke R, Mayet WJ, Galle PR, Neurath MF.
    Am J Gastroenterol; 2000 May; 95(5):1201-7. PubMed ID: 10811328
    [Abstract] [Full Text] [Related]

  • 18. Pharmacokinetic evaluation of mycophenolate mofetil for pemphigus.
    Doukaki S, Pistone G, Aricò M, Bongiorno MR.
    Expert Opin Drug Metab Toxicol; 2011 Feb; 7(2):237-44. PubMed ID: 21192770
    [Abstract] [Full Text] [Related]

  • 19. Randomized controlled open-label trial of four treatment regimens for pemphigus vulgaris.
    Chams-Davatchi C, Esmaili N, Daneshpazhooh M, Valikhani M, Balighi K, Hallaji Z, Barzegari M, Akhyani M, Ghodsi SZ, Seirafi H, Nazemi MJ, Mortazavi H, Mirshams-Shahshahani M.
    J Am Acad Dermatol; 2007 Oct; 57(4):622-8. PubMed ID: 17583373
    [Abstract] [Full Text] [Related]

  • 20. Evaluation of mycophenolate mofetil as a steroid-sparing agent in pemphigus: a randomized, prospective study.
    Ioannides D, Apalla Z, Lazaridou E, Rigopoulos D.
    J Eur Acad Dermatol Venereol; 2012 Jul; 26(7):855-60. PubMed ID: 21752101
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.